GFAP and Alzheimer disease: In the 1970s, broadly termed “reactive astrocytes”, an increase in the expression of the intermediate filament protein, GFAP (glial fibrillary acidic protein), was discovered [47], which is also a significant characteristic of astrocytes in AD.